SMARCAL1 and dysplasia: Two homozygous variants survived the prioritization process (Table 2), but only the p.Arg561His in SMARCAL1 emerged as the most prominent candidate, with a CADD score of 32 and affecting a disease gene causing a clinical condition similar to that presented by the two siblings, Schimke immunoosseous dysplasia (MIM 242900).